 |
|
 |
|
|
 |
|||
       |
|||
|
|||
 |
|||
|
|||
Segment Results - 1st Quarter Fiscal Year 2010
- TECHNE Corporation and Subsidiaries
- Hematology Division
- Biotechnology Division
- R&D Systems Europe (in £'s)
- R&D Systems Europe (in $'s)
- Corporate and Other
(in thousands of $’s, except per share data)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||
| First Quarter | Percent Of Sales | First Quarter | |
| Sales | 66,534 | 100% | (2,790) |
| Cost of sales | 12,901 | 19% | (185) |
| Gross margin | 53,633 | 81% | (2,605) |
| Gross margin percentage | 80.6% | ||
| SG&A expense | 8,038 | 12% | (802) |
| R&D expense | 6,154 | 10% | 244 |
| Amortization expense | 240 | -- | -- |
| Interest income | (1,168) | (2%) | 1,719 |
| Other non-operating ex., net | 662 | 1% | (525) |
| 13,926 | 21% | 636 | |
| Earnings before income taxes | 39,707 | 60% | (3,241) |
| Income taxes | 12,935 | 20% | (1,420) |
| 26,772 | 40% | (1,821) | |
| Diluted earnings per share | .72 | ||
| Weighted average diluted shares outstanding | 37,339 | ||
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||
| First Quarter | Percent Of Sales | First Quarter | |
| Sales | 4,668 | 100% | 422 |
| Cost of sales | 2,319 | 50% | (50) |
| Gross margin | 2,349 | 50% | 472 |
| Gross margin percentage | 50.3% | ||
| SG&A expense | 370 | 8% | (66) |
| R&D expense | 198 | 4% | 5 |
| Interest, net | (72) | (2%) | 30 |
| 496 | 10% | (31) | |
| Pretax result | 1,853 | 40% | 503 |
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||
| First Quarter | Percent Of Sales | First Quarter | |
| Sales | 51,696 | 100% | (2,203) |
| Intersegment sales | (7,668) | 94 | |
| 44,028 | (2,109) | ||
| Cost of sales | 9,885 | 19% | (362) |
| Intersegment sales | (7,598) | (137) | |
| 2,287 | (499) | ||
| Gross margin | 41,741 | 81% | (1,610) |
| Gross margin percentage | 80.9% | ||
| SG&A expense | 4,734 | 9% | (407) |
| R&D expense | 5,956 | 12% | 239 |
| Amortization expense | 240 | -- | -- |
| Interest, net | (771) | (1%) | 313 |
| Other expense | 2 | -- | 4 |
| 10,161 | 20% | 149 | |
| Pretax result | 31,580 | 61% | (1,759) |
(1) Includes R&D Systems' Biotechnology Division, BiosPacific,
Inc. and R&D China
Back to Top
(in thousands of £'s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||
| First Quarter | Percent Of Sales | First Quarter | |
| Sales | 10,881 | 100% | 706 |
| Cost of sales | 5,061 | 47% | 801 |
| Gross margin | 5,820 | 53% | (95) |
| Gross margin percentage | 53.5% | ||
| SG&A expense | 1,191 | 11% | (33) |
| Interest income | (87) | (1%) | 703 |
| Exchange loss/(gain) | (89) | (1%) | (349) |
| 1,015 | 9% | 321 | |
| Pretax result | 4,805 | 44% | (416) |
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | ||
| First Quarter | Percent Of Sales | First Quarter | |
| Sales | 17,838 | 100% | (1,103) |
| Cost of sales | 8,295 | 47% | 364 |
| Gross margin | 9,543 | 53% | (1,467) |
| Gross margin percentage | 53.5% | ||
| SG&A expense | 1,952 | 11% | (331) |
| Interest income | (143) | (1%) | 1,328 |
| Exchange loss | (145) | (1%) | (621) |
| 1,664 | 9% | 376 | |
| Pretax result | 7,879 | 44% | (1,843) |
Back to Top
(in thousands of $’s)
| Fiscal 2010 | Increase (Decrease) From Fiscal 2009 | |
| First Quarter | First Quarter | |
| Interest income | 182 | (48) |
| Rental income | 81 | (18) |
| 263 | (66) | |
| SG&A expense | 982 | 2 |
| Other-Building expenses | 548 | (5) |
| Other-Equity Investment losses | 338 | 79 |
| 1,868 | 76 | |
| Pretax result | (1,605) | (142) |
Back to Top
(2) Unallocated corporate expenses and Techne’s share of losses by Hemerus Medical, LLC
Back to Top
|
Home -
Company News -
Financial Information -
About TECHNE -
Map/Directions -
Products -
Contact Us
TECHNE CORPORATION 614 McKinley Place N.E. Minneapolis, MN 55413-2610 Phone: (612)379-8854 Fax: (612)379-6580 e-mail: techinfo@techne-corp.com * Up to a 15 minute delay on Market Overview. Please consult your financial advisor for an up-to-minute quote. Quote provided by Barchart.com. |